Iread the recent editorial1 on prostate cancer with interest. The issue of screening for this
disease is important for family physicians and their patients. With some concern, however, I …

DS, a 55-year-old African-American man, comes into your office for a physical examination.
While talking about his family history, you learn that his father had prostate cancer. DS asks …

Seneca Early this summer a healthy 62-year-old man with a history of colorectal cancer
came to see me for his periodic health examination. In an effort to embrace patient-centred …

Alan Katz, MB CHB, MSC, CCFP, FCFP Jeffrey J. Sisler, MD, MCLSC, CCFP, FCFP little
over a year ago, the Canadian Prostate Cancer Network (CPCN) launched the “Living Proof” …

In August, we presented a case involving a 55-year-old man seeking guidance from his
primary care physician on whether to pursue screening for prostate cancer with a yearly …

The justification for systematically screening asymptomatic patients for a condition is based
on the severity of the disease, the existence of an effective method of detection, the efficacy …

The justification for systematically screening asymptomatic patients for a condition is based
on the severity of the disease, the existence of an effective method of detection, the efficacy …

To the Editor: Gillette et al analyze how PSA screening for age 70 and over, a low-value
service, is being implemented in the United States. 1 For PSA screening, the United States …

TO THE EDITOR: I first want to compliment Dr. Spann on a well-written editorial'regarding
prostate cancer, a topic that is rife with controversy, subspecialist and specialty society (eg …

The initial sentiment amongst my colleagues was that screening for and treatment of early
stage prostate cancer should not be a priority for the medical field. They concluded that PSA …